Additionally, a high proportion of cells positive for putative GS-cell markers such as CD133, nestin, or PDPN was a negative prognostic factor for progression-free survival (PFS) and overall survival (OS) in GBM patients [11, 25–28]. Here, PROM1 is linked to glioblastoma.